Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cytomegalovirus Infection

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 39 articles:
HTML format



Single Articles


    June 2022
  1. LILLERI D, Tassis B, Pugni L, Ronchi A, et al
    Prevalence, outcome, and prevention of congenital cytomegalovirus infection in neonates born to women with preconception immunity (CHILd study).
    Clin Infect Dis. 2022 Jun 19. pii: 6611487. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  2. ALYSSA FITZPATRICK A, Cooper C, Vasilunas N, Ritchie B, et al
    Describing the impact of maternal hyperimmune globulin and valaciclovir on the outcomes of CMV infection in pregnancy: a systematic review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570695. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  3. SU Y, Stern A, Karantoni E, Nawar T, et al
    Impact of letermovir primary Cytomegalovirus (CMV) prophylaxis on 1-year mortality after allogeneic hematopoietic cell transplantation (HCT): a retrospective cohort study.
    Clin Infect Dis. 2022 Jan 3. pii: 6494526. doi: 10.1093/cid/ciab1064.
    PubMed     Abstract available


    December 2021
  4. AVERY RK, Alain S, Alexander BD, Blumberg EA, et al
    Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial.
    Clin Infect Dis. 2021 Dec 2. pii: 6448443. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  5. LANZIERI TM, Kruszon-Moran D, Dollard SM
    Cytomegalovirus seroprevalence among U.S. children 1 to 5 years of age: The National Health and Nutrition Examination Surveys (NHANES), 2017 - March 2020 Pre-pandemic dataset.
    Clin Infect Dis. 2021 Nov 8. pii: 6423497. doi: 10.1093.
    PubMed    


    July 2021
  6. SEMMES EC, Li SH, Hurst JH, Yang Z, et al
    Congenital human cytomegalovirus infection is associated with decreased transplacental IgG transfer efficiency due to maternal hypergammaglobulinemia.
    Clin Infect Dis. 2021 Jul 14. pii: 6321289. doi: 10.1093.
    PubMed     Abstract available


  7. WAMALWA D, Njuguna I, Maleche-Obimbo E, Begnel E, et al
    Cytomegalovirus viremia and clinical outcomes in Kenyan children diagnosed with HIV in hospital.
    Clin Infect Dis. 2021 Jul 2. pii: 6313248. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  8. PAEZ-VEGA A, Gutierrez-Gutierrez B, Aguera ML, Facundo C, et al
    Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated with Antithymocyte Globulin: A Randomized Clinical Trial.
    Clin Infect Dis. 2021 Jun 22. pii: 6316194. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  9. SASSINE J, Khawaja F, Shigle TL, Handy V, et al
    Refractory and Resistant Cytomegalovirus after Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era.
    Clin Infect Dis. 2021 Apr 8. pii: 6217453. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  10. WALL N, Godlee A, Geh D, Jones C, et al
    Latent cytomegalovirus infection and previous capsular polysaccharide vaccination predict poor vaccine responses in older adults, independent of chronic kidney disease.
    Clin Infect Dis. 2021 Mar 17. pii: 6174428. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  11. DORFMAN JR, Balla SR, Pathirana J, Groome MJ, et al
    In utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection: evidence for boosting but not protection.
    Clin Infect Dis. 2021 Feb 9. pii: 6131727. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  12. PEPPA D, Reeves M
    Poor responses to Pneumococcal vaccination in CKD patients - do we need to talk about cytomegalovirus again?
    Clin Infect Dis. 2021 Jan 30. pii: 6124513. doi: 10.1093.
    PubMed    


    December 2020
  13. LANZIERI TM, Kruszon-Moran D, Link-Gelles R, Wong P, et al
    Breastfeeding duration and cytomegalovirus seroprevalence among U.S. children aged 1-5 years: The National Health and Nutrition Examination Surveys, 2011-2012 and 2017-2018.
    Clin Infect Dis. 2020 Dec 30. pii: 6055165. doi: 10.1093/cid/ciaa1900.
    PubMed    


  14. AKAHOSHI Y, Kimura SI, Inamoto Y, Seo S, et al
    Effect of cytomegalovirus reactivation with or without acute graft-versus-host disease on the risk of nonrelapse mortality.
    Clin Infect Dis. 2020 Dec 20. pii: 6042338. doi: 10.1093/cid/ciaa1871.
    PubMed     Abstract available


  15. PERRY WA, Paulus JK, Price LL, Snydman DR, et al
    Association between lymphopenia at one month post-transplant and infectious outcomes or death in heart transplant recipients.
    Clin Infect Dis. 2020 Dec 6. pii: 6024974. doi: 10.1093/cid/ciaa1800.
    PubMed     Abstract available


    November 2020
  16. HAMEIRI BOWEN D, Sovershaeva E, Charlton B, Schive C, et al
    Cytomegalovirus-Specific Immunoglobulin G is associated with chronic lung disease in children and adolescents from sub-Saharan Africa with perinatal HIV infection.
    Clin Infect Dis. 2020 Nov 26. pii: 6006874. doi: 10.1093/cid/ciaa1757.
    PubMed     Abstract available


  17. IMLAY HN, Kaul DR
    Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.
    Clin Infect Dis. 2020 Nov 17. pii: 5983750. doi: 10.1093/cid/ciaa1713.
    PubMed     Abstract available


    August 2020
  18. PETERSEN MR, Patel EU, Abraham AG, Quinn TC, et al
    Changes in Cytomegalovirus Seroprevalence Among U.S. Children Aged 1 to 5 Years: The National Health and Nutrition Examination Surveys.
    Clin Infect Dis. 2020 Aug 10. pii: 5890412. doi: 10.1093/cid/ciaa1168.
    PubMed     Abstract available


  19. ISNARD S, Ramendra R, Lin J, Kant S, et al
    Anti-CMV IgG is linked to CD4 T-cell count decay in HIV elite controllers.
    Clin Infect Dis. 2020 Aug 5. pii: 5881439. doi: 10.1093/cid/ciaa1129.
    PubMed     Abstract available


    July 2020
  20. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Cost effectiveness of preemptive therapy versus prophylaxis in a randomized clinical trial for the prevention of CMV disease in seronegative liver transplant recipients with seropositive donors.
    Clin Infect Dis. 2020 Jul 27. pii: 5876605. doi: 10.1093/cid/ciaa1051.
    PubMed     Abstract available


    June 2020
  21. GIBSON L
    An interferon-gamma release assay for evaluation of cell-mediated immunity in infants with congenital CMV infection.
    Clin Infect Dis. 2020 Jun 5. pii: 5854052. doi: 10.1093.
    PubMed    


  22. CAPRETTI MG, Marsico C, Chiereghin A, Gabrielli L, et al
    Immune Monitoring Using QuantiFERON(R)-CMV Assay in Congenital Cytomegalovirus Infection: Correlation With Clinical Presentation and CMV DNA load.
    Clin Infect Dis. 2020 Jun 5. pii: 5854054. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  23. JARRELL AS, Crow JR, Strout SE, Kruer RM, et al
    Valganciclovir dosing for cytomegalovirus prophylaxis in solid organ transplant recipients on continuous veno-venous hemodialysis.
    Clin Infect Dis. 2020 May 7. pii: 5831845. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  24. DENOBLE AE, Saccoccio FM, Permar SR, Hughes BL, et al
    Prenatal Treatment of Congenital Cytomegalovirus with Valganciclovir: a Case Report.
    Clin Infect Dis. 2020 Mar 21. pii: 5810782. doi: 10.1093.
    PubMed     Abstract available


  25. AREND SM, Jedema I
    To Bridge, Blossom, or Boost: That Is the Question.
    Clin Infect Dis. 2020;70:1438-1441.
    PubMed    


  26. ZHAO XY, Pei XY, Chang YJ, Yu XX, et al
    First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation.
    Clin Infect Dis. 2020;70:1429-1437.
    PubMed     Abstract available


    February 2020
  27. JARQUE M, Crespo E, Melilli E, Gutierrez A, et al
    Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial.
    Clin Infect Dis. 2020 Feb 20. pii: 5686894. doi: 10.1093/cid/ciz1209.
    PubMed     Abstract available


  28. CHEMALY RF, El Haddad L, Winston DJ, Rowley SD, et al
    Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study.
    Clin Infect Dis. 2020 Feb 20. pii: 5740597. doi: 10.1093/cid/ciz1210.
    PubMed     Abstract available


  29. KIM SH
    Interferon-gamma Release Assay for Cytomegalovirus (IGRA-CMV) for Risk Stratification of Posttransplant CMV Infection: Is It Time to Apply IGRA-CMV in Routine Clinical Practice?
    Clin Infect Dis. 2020 Feb 20. pii: 5686893. doi: 10.1093/cid/ciz1211.
    PubMed    


  30. ROWLAND-JONES S, Yindom LM, Ferrand R
    Reply to Cevik et al.
    Clin Infect Dis. 2020;70:990-991.
    PubMed    


  31. BELGA S, MacDonald C, Chiang D, Kabbani D, et al
    Donor graft CMV-serostatus and the risk of arterial and venous thrombotic events in seronegative recipients after non-thoracic solid organ transplantation.
    Clin Infect Dis. 2020 Feb 6. pii: 5728524. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  32. LERUEZ-VILLE M, Faure-Bardon V, Magny JF, Parodi M, et al
    Reply to Park et al, Muldoon et al, and Perillaud-Dubois et al.
    Clin Infect Dis. 2020;70:176-177.
    PubMed    


    December 2019
  33. UCHIDA A, Tanimura K, Morizane M, Fujioka K, et al
    Clinical factors associated with congenital cytomegalovirus infection: A cohort study of pregnant women and newborns.
    Clin Infect Dis. 2019 Dec 2. pii: 5649307. doi: 10.1093/cid/ciz1156.
    PubMed     Abstract available


    October 2019
  34. LERUEZ-VILLE M, Guilleminot T, Stirnemann J, Salomon LJ, et al
    Quantifying the burden of congenital CMV infection (cCMV) with long-term sequelae in subsequent pregnancies of women seronegative at their first pregnancy.
    Clin Infect Dis. 2019 Oct 30. pii: 5610250. doi: 10.1093/cid/ciz1067.
    PubMed     Abstract available


  35. NIGRO G, Adler SP
    High-dose CMV hyperimmune globulin (HIG) and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary cytomegalovirus (CMV) infection.
    Clin Infect Dis. 2019 Oct 20. pii: 5601168. doi: 10.1093/cid/ciz1030.
    PubMed     Abstract available


  36. SCHLEISS MR
    The Value of Hyperimmune Globulin (HIG) in Pregnancies Complicated by Cytomegalovirus Infection: A Continuing Saga.
    Clin Infect Dis. 2019 Oct 20. pii: 5601169. doi: 10.1093/cid/ciz1036.
    PubMed    


  37. RAMENDRA R, Isnard S, Lin J, Fombuena B, et al
    CMV seropositivity is associated with increased microbial translocation in people living with HIV and uninfected controls.
    Clin Infect Dis. 2019 Oct 14. pii: 5586739. doi: 10.1093/cid/ciz1001.
    PubMed     Abstract available


    June 2018
  38. MOORE CC, Jacob ST, Banura P, Zhang J, et al
    Etiology of Sepsis in Uganda using a Quantitative PCR-based TaqMan Array Card.
    Clin Infect Dis. 2018 Jun 4. pii: 5032704. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  39. MEHTA K, Im A, Rahman F, Wang H, et al
    Epidemiology and Outcomes of Hematopoietic Stem Cell Transplant in HIV (+) Patients from 1998 to 2012: A Nationwide Analysis.
    Clin Infect Dis. 2018 Jan 6. pii: 4792772. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: